Rigor, reproducibility, and in vitro cerebrospinal fluid assays: The devil in the details
Authors:
- 25 April 2017
- journal article
- letter
- Published by Wiley in Annals of Neurology
- Vol. 81 (6) , 904-907
Abstract
Click on the article title to read more.Keywords
Funding Information
- National Institutes of Health (GM008602, NS007480, NS083748, NS089719)
- James S. McDonnell Foundation
- Mind Science Foundation
This publication has 18 references indexed in Scilit:
- Flumazenil for the Treatment of Refractory Hypersomnolence: Clinical Experience with 153 PatientsJournal of Clinical Sleep Medicine, 2016
- Clarithromycin in γ‐aminobutyric acid–Related hypersomnolence: A randomized, crossover trialAnnals of Neurology, 2015
- Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: Clinical experienceJournal of Psychopharmacology, 2013
- Endogenous Positive Allosteric Modulation of GABAA Receptors by Diazepam binding inhibitorNeuron, 2013
- Modulation of Vigilance in the Primary Hypersomnias by Endogenous Enhancement of GABAAReceptorsScience Translational Medicine, 2012
- Dose-dependent effects of Flumazenil on cognition, mood, and cardio-respiratory physiology in healthy volunteersBritish Dental Journal, 2000
- Pharmacology of flumazenilActa Anaesthesiologica Scandinavica, 1995
- Chemical Characterization of a Family of Brain Lipids That Induce SleepScience, 1995
- Endogenous benzodiazepine receptor ligands in idiopathic recurring stuporThe Lancet, 1992
- Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788Psychopharmacology, 1986